First patient treated in Geron stem cell trial
WASHINGTON (Reuters) – U.S. doctors have begun treating the first patient to receive human embryonic stem cells, but details of the landmark clinical trial are being kept confidential, Geron Corp said on Monday.
Read more on Reuters via Yahoo!7 News

Clicking advertisements helps keep this site running. thank you!